¼¼°èÀÇ GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½º ½ÃÀå : ¼¼Æ÷ À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð ¹× Á¡À¯À², ¿¹Ãø(2025-2032³â)
GMP Cell Banking Services Market, By Cell Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1629213
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 395 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,702,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,728,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,174,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸®Æ÷Æ® ÇÏÀ̶óÀÌÆ®

GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½º ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 8¾ï 5,623¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2025-2032³â¿¡ 13.7%ÀÇ CAGR·Î È®´ë

GMP ¼¿¹ðÅ· ¼­ºñ½º ½ÃÀå ¿ªÇÐ

¹ÙÀÌ¿ÀÀǾàǰ ¼ö¿ä Áõ°¡·Î GMP ¼¼Æ÷ÀºÇà ¼­ºñ½º ½ÃÀå ¼ºÀå °ßÀÎ

GMP(Good Manufacturing Practice) ¼¼Æ÷ÀºÇà ¼­ºñ½º ½ÃÀåÀº ¹ÙÀÌ¿ÀÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ À¯ÀüÀÚ Ä¡·á, ¼¼Æ÷ ±â¹Ý Ä¡·á, Àç»ýÀÇ·á µî ¼¼°è ¹ÙÀÌ¿ÀÀǾàǰ ºÐ¾ß°¡ È®´ëµÊ¿¡ µû¶ó °íǰÁúÀÇ ÄÄÇöóÀ̾𽺸¦ ÁؼöÇÏ´Â ¼¼Æ÷ÀºÇà¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA)¿¡ µû¸£¸é ÇöÀç 1,000°³ ÀÌ»óÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á Á¦Ç°ÀÌ ¿¬±¸ ÁßÀ̰ųª ½ÂÀÎµÈ »óÅÂÀÔ´Ï´Ù. ¶ÇÇÑ ÃÖ±Ù 20°³ ÀÌ»óÀÇ ¼¼Æ÷ ±â¹Ý Ä¡·á¹ýÀÌ ½ÂÀεǴ µî ¸ÂÃãÇü ÀÇ·áÀÇ ¹ßÀüµµ ÀÌ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¾Ï ¹× À¯Àü¼º Áúȯ¿¡ ´ëÇÑ ¼¼Æ÷ ±â¹Ý Ä¡·á¹ýÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±ÔÁ¦ ±âÁذú Á¦Ç° ǰÁúÀ» º¸ÀåÇϱâ À§ÇÑ GMP Áؼö ½Ã¼³ÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ ½ÃÀåÀº ³ôÀº ¿î¿µ ºñ¿ë°ú ±î´Ù·Î¿î ±ÔÁ¦ ¿ä°Ç°ú °°Àº ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµÀü¿¡µµ ºÒ±¸ÇÏ°í Æ¯È÷ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ´Â ¾Æ½Ã¾ÆÅÂÆò¾ç°ú °°Àº ½ÅÈï ½ÃÀå¿¡¼­´Â GMP ¼¼Æ÷ÀºÇà ±â´ÉÀ» È®ÀåÇÒ ¼ö ÀÖ´Â ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù.

GMP ¼¼Æ÷ÀºÇà ¼­ºñ½º ½ÃÀå : ÁÖ¿ä °í·Á»çÇ×

¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 13.7%%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼Æ÷º°·Î´Â Æ÷À¯·ù ¼¼Æ÷°¡ 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÇ¾ú½À´Ï´Ù.

¿ëµµº°·Î´Â ¹ÙÀÌ¿ÀÁ¦¾à ±â¾÷ÀÌ 2024³â ÁÖ¿ä ¿ëµµ¿´½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ¸ÅÃâÀ» âÃâÇÒ ÁÖ¿ä ½ÃÀåÀÔ´Ï´Ù.

GMP ¼¼Æ÷ÀºÇà ¼­ºñ½º ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼®

GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½º ¼¼°è ½ÃÀåÀº ¼¼Æ÷ À¯Çü, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº ¼¼Æ÷ÀÇ À¯Çü¿¡ µû¶ó Æ÷À¯·ù, ¹Ì»ý¹°, °ïÃæ, È¿¸ð, Á¶·ù, Áٱ⼼Æ÷ µî 6°¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. Æ÷À¯·ù ¼¼Æ÷´Â ¹ÙÀÌ¿ÀÀǾàǰ »ý»ê¿¡ ³Î¸® »ç¿ëµÇ¹Ç·Î °¡Àå ¿ì¼±¼øÀ§°¡ ³ô½À´Ï´Ù. Áٱ⼼Æ÷´Â Àç»ýÀÇ·áÀÇ ¹ßÀü¿¡ ÈûÀÔ¾î ±× µÚ¸¦ ÀÕ°í ÀÖ½À´Ï´Ù. ¹Ì»ý¹° ¼¼Æ÷, È¿¸ð ¼¼Æ÷, °ïÃæ ¼¼Æ÷, Á¶·ù ¼¼Æ÷ ¹× ±âŸ ¼¼Æ÷ À¯ÇüÀº ¿ëµµ°¡ ´Ù¸¥ Ãß°¡ ºÎ¹®ÀÔ´Ï´Ù.

½ÃÀåÀº ¿ëµµ¿¡ µû¶ó ¹ÙÀÌ¿À Á¦¾àȸ»ç¿Í CMOÀÇ µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ¹ÙÀÌ¿À Á¦¾àȸ»ç´Â ÀǾàǰ °³¹ß ¹× Á¦Á¶¿¡ ÀÖÀ¸¸ç, ¼¼Æ÷ÁÖ ¼ö¿ä°¡ ³ô±â ¶§¹®¿¡ ÁÖ¿ä ±â¾÷ÀÌ µÇ°í ÀÖ½À´Ï´Ù. CMO´Â Á¦¾à »ê¾÷¿¡¼­ ¼¼Æ÷ÀºÇà À§Å¹ ¼­ºñ½ºÀÇ ÁÖ¿ä ÆÄÆ®³Ê·Î¼­ ¼¼Æ÷ÀºÇà À§Å¹ ¼­ºñ½ºÀÇ ÁÖ¿ä ÆÄÆ®³Ê·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

GMP ¼¼Æ÷ÀºÇà ¼­ºñ½º ½ÃÀå : Áö¿ªº° ºÐ¼®

GMP ¼¼Æ÷ÀºÇà ¼­ºñ½º ½ÃÀåÀº Áö¿ªÀû º¯µ¿ÀÌ ¶Ñ·ÇÇϸç, ÁÖ¿ä Á¦¾à»çÀÇ Á¸Àç, ÷´Ü ÀÇ·á ÀÎÇÁ¶ó, ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀÌ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÏ¿© ºÏ¹Ì°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¹Ì±¹Àº ¼¼Æ÷Ä¡·á ¹× À¯ÀüÀÚ Ä¡·á¿¡ ´ë±Ô¸ð ÅõÀÚ¸¦ ÇÏ´Â °­·ÂÇÑ ¹ÙÀÌ¿À Á¦¾à »ê¾÷À¸·Î ÀÎÇØ ÁÖ¿ä °ÅÁ¡ÀÌ µÇ°í ÀÖ½À´Ï´Ù. À¯·´ ½ÃÀåµµ À¯·´ÀǾàǰû(EMA)°ú °°Àº È®¸³µÈ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©ÀÇ ÇýÅÃÀ» ¹Þ¾Æ ¼¼Æ÷ÀºÇà ¼­ºñ½ºÀÇ ³ôÀº ǰÁú ±âÁØÀ» º¸ÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯·´¿¬ÇÕ(EU)Àº »ý¸í°øÇÐ Çõ½ÅÀ» Àû±ØÀûÀ¸·Î ÃßÁøÇϰí ÀÖÀ¸¸ç, GMP ¼¼Æ÷ÀºÇà ¼­ºñ½º¿¡ À¯¸®ÇÑ È¯°æÀ» Á¦°øÇÕ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â »ý¸í°øÇÐ ¿¬±¸ ¹× Á¦Á¶¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ÀÎÇØ ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Áß±¹, ÀϺ», Àεµ¿Í °°Àº ±¹°¡µéÀº Á¤ºÎ ±¸»ó°ú »ý¹°Á¦Á¦ ¹× Àç»ýÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ÁÖ¿ä ±â¾÷À¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. °³ÀθÂÃãÇü ÀÇ·á °³¹ß¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÓ»ó½ÃÇè Ȱµ¿ÀÌ È°¹ßÇØÁö¸é¼­ ÀÌ Áö¿ª ½ÃÀå È®´ë°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

GMP ¼¼Æ÷ÀºÇà ¼­ºñ½º ½ÃÀå : °æÀï ±¸µµ

GMP ¼¼Æ÷ÀºÇà ¼­ºñ½º ½ÃÀåÀº °æÀïÀÌ Ä¡¿­Çϸç, ¿©·¯ À¯·Â ±â¾÷ÀÌ ´Ù¾çÇÑ ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷À¸·Î´Â Lonza Group, Charles River Laboratories, WuXi AppTec, Merck KGaA µîÀÌ ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº ¼¼Æ÷ÁÖ °³¹ß, ³Ãµ¿º¸°ü, ¿ì¼öÀǾàǰ Á¦Á¶ ¹× ǰÁú°ü¸®±âÁØ(GMP)¿¡ µû¸¥ ±ÔÁ¦ Áؼö¿¡ ÀÖÀ¸¸ç, °­·ÂÇÑ ¿ª·®À» ÀÎÁ¤¹Þ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ·ÐÀÚ ±×·ìÀº ¼¼Æ÷ÀºÇà¿¡¼­ ÃÖÁ¾ Á¦Ç° »ý»ê±îÁö Á¾ÇÕÀûÀÎ ¼­ºñ½º¸¦ Á¦°øÇÏ¸ç ºÏ¹Ì¿Í À¯·´¿¡¼­ °­·ÂÇÑ ¿µÇâ·ÂÀ» ¹ßÈÖÇϰí ÀÖ½À´Ï´Ù. Charles River Laboratories´Â ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·áÁ¦ °³¹ß °¡¼ÓÈ­¿¡ ÁßÁ¡À» µÎ°í À§Å¹ ¿¬±¸ ¹× ¼¼Æ÷ÀºÇà ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù. ¿ì½Ã ¾ÛÅØÀº ¼¼Æ÷Ä¡·áÁ¦ °³¹ßÀ» À§ÇÑ ¿£µå Åõ ¿£µå ¼Ö·ç¼ÇÀ» Á¦°øÇÏ°í ¼¼°è °í°´ ±â¹ÝÀ» È®º¸ÇÏ¿© ÀÔÁö¸¦ °­È­Çϰí ÀÖÀ¸¸ç, Merck KGaA´Â ¼¼Æ÷¹è¾ç, À¯ÀüÀÚ ÆíÁý ¹× ¼¼Æ÷ ±â¹Ý ºÐ¼® ¼­ºñ½º ºÐ¾ßÀÇ Àü¹®¼ºÀ¸·Î À¯¸íÇÑ Áß¿äÇÑ °æÀï»çÀÔ´Ï´Ù. ÀÔ´Ï´Ù. ½ÃÀåÀÌ È®´ëµÊ¿¡ µû¶ó ÀÌµé ±â¾÷Àº ÷´Ü ±â¼ú ¹× Àü·«Àû ÆÄÆ®³Ê½Ê¿¡ Áö¼ÓÀûÀ¸·Î ÅõÀÚÇÏ¿© ¼­ºñ½º¸¦ °­È­ÇÏ°í ¹ÙÀÌ¿ÀÀǾàǰ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½º ½ÃÀå °³¿ä

Á¦2Àå °³¿ä

Á¦3Àå GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½ºÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½º ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½º ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½º ½ÃÀå ±¸µµ

Á¦7Àå GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½º ½ÃÀå : ¼¼Æ÷ À¯Çüº°

Á¦8Àå GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½º ½ÃÀå : ¿ëµµº°

Á¦9Àå GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½º ½ÃÀå : Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® : GMP ¼¼Æ÷ ÀºÇà ¼­ºñ½º¾÷°è

Á¦12Àå AnalystViewÀÇ Àü¹æÀ§Àû ºÐ¼®

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

GMP Cell Banking Services Market size was valued at US$ 856.23 Million in 2024, expanding at a CAGR of 13.7% from 2025 to 2032.

The GMP (Good Manufacturing Practice) Cell Banking Services Market focuses on the production and storage of cell lines under strictly regulated conditions to support research and biopharmaceutical manufacturing. With the growing demand for biopharmaceuticals, these services ensure high-quality, compliant cell lines for therapeutic production. Increasing applications in regenerative medicine, cell therapies, and vaccine development have expanded the market. However, challenges such as high costs and regulatory complexity may limit growth. For example, in 2020, the global regenerative medicine market was valued at $5.4 billion, pushing demand for GMP cell banking services. Opportunities lie in the growth of personalized medicine, the development of novel biotherapeutics, and expanding regulatory frameworks supporting cell-based treatments. With advancements in cryopreservation technologies and increasing industry collaboration, the market is set to experience continuous growth.

Gmp Cell Banking Services Market- Market Dynamics

Rising Demand for Biopharmaceuticals Drives Growth in the GMP Cell Banking Services Market

The GMP (Good Manufacturing Practice) Cell Banking Services Market is experiencing significant growth due to the rising demand for biopharmaceuticals. As the global biopharmaceutical sector expands, especially in gene therapies, cell-based therapies, and regenerative medicine, the need for high-quality, compliant cell banks has surged. According to the U.S. Food and Drug Administration (FDA), over 1,000 cell and gene therapy products are currently under investigation or have been approved. Furthermore, advancements in personalized medicine, with over 20 cell-based therapies approved in recent years, have contributed to this market's growth. The increasing adoption of cell-based therapeutics, especially for cancer and genetic disorders, is driving the need for GMP-compliant facilities to ensure regulatory standards and product quality. However, the market faces challenges such as high operational costs and stringent regulatory requirements. Despite these challenges, opportunities exist in expanding GMP cell banking capabilities, especially in emerging markets like Asia-Pacific, which are seeing increased investments in biotechnology research and development.

Gmp Cell Banking Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.7% over the forecast period (2025-2032)

Based on Cell Type segmentation, Mammalian Cells was predicted to show maximum market share in the year 2024

Based on application segmentation, Biopharmaceutical Companies was the leading application in 2024

Based on region, North America was the leading revenue generator in 2024

Gmp Cell Banking Services Market- Segmentation Analysis:

The Global GMP Cell Banking Services Market is segmented based on Cell Type, Application, End-User, and Region.

The market is divided into six categories based on Cell Type: Mammalian, Microbial, Insect, Yeast, Avian, and Stem Cell. Mammalian cells hold the highest priority due to their widespread use in biopharmaceutical production. Stem cells follow closely, driven by advances in regenerative medicine. Microbial, yeast, insect, avian, and other cell types are further segments with varying applications.

The market is divided into two categories based on application: Biopharmaceutical Companies and Contract Manufacturing Organizations. Biopharmaceutical companies lead due to the high demand for cell lines in drug development and production. Contract Manufacturing Organizations (CMOs) follow closely, serving as key partners for outsourced cell banking services in the pharmaceutical industry.

Gmp Cell Banking Services Market- Geographical Insights

The GMP Cell Banking Services Market shows notable geographical variation, with North America leading the market, primarily driven by the presence of key pharmaceutical companies, advanced healthcare infrastructure, and stringent regulatory standards. The United States, in particular, is a major hub due to its strong biopharmaceutical industry, with extensive investments in cell and gene therapies. The European market follows closely, benefiting from established regulatory frameworks, such as the European Medicines Agency (EMA), which ensures high-quality standards for cell banking services. Moreover, the European Union has been actively promoting biotechnology innovations, providing a favorable environment for GMP cell banking services. In the Asia-Pacific region, the market is witnessing significant growth, driven by increased investments in biotechnology research and manufacturing. Countries like China, Japan, and India are emerging as key players, supported by government initiatives and the growing demand for biologics and regenerative medicines. The growing focus on developing personalized medicine and increasing clinical trial activities are also propelling market expansion in the region.

Gmp Cell Banking Services Market- Competitive Landscape:

The GMP Cell Banking Services Market is highly competitive, with several prominent players offering a wide range of services. Key market participants include Lonza Group, Charles River Laboratories, WuXi AppTec, and Merck KGaA, among others. These companies are recognized for their strong capabilities in cell line development, cryopreservation, and regulatory compliance in line with Good Manufacturing Practice (GMP) standards. Lonza Group is particularly influential, providing comprehensive services from cell banking to final product manufacturing, with a strong presence in North America and Europe. Charles River Laboratories is another key player, offering contract research and cell banking services, focusing on accelerating cell and gene therapy development. WuXi AppTec has strengthened its position by offering end-to-end solutions for cell therapy development, catering to a global customer base. Merck KGaA is a significant competitor, known for its expertise in cell culture, gene editing, and cell-based assay services. As the market expands, these companies continue to invest in advanced technologies and strategic partnerships to enhance their offerings and cater to the increasing demand for biopharmaceuticals.

Recent Developments:

In May 2024, REPROCELL expanded its GMP-grade stem cell Master Cell Bank service, now offering Human Induced Pluripotent Cells (hiPSCs) for therapeutic applications. The new Cytocentric Xvivo system enhances cell culture consistency, reduces contamination risks, and accelerates GMP product production.

In August 2019, Sartorius launched new services for mammalian cell bank manufacture, enhancing its GMP-compliant capabilities. These services streamline the production process, ensuring high-quality cell banks for biopharmaceutical applications, thereby supporting clients in accelerating their development timelines and improving regulatory compliance.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GMP CELL BANKING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL GMP CELL BANKING SERVICES MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL GMP CELL BANKING SERVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL GMP CELL BANKING SERVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL GMP CELL BANKING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Gmp Cell Banking Services Market Overview

2. Executive Summary

3. Gmp Cell Banking Services Key Market Trends

4. Gmp Cell Banking Services Industry Study

5. Gmp Cell Banking Services Market: Impact of Escalating Geopolitical Tensions

6. Gmp Cell Banking Services Market Landscape

7. Gmp Cell Banking Services Market - By Cell Type

8. Gmp Cell Banking Services Market - By Application

9. Gmp Cell Banking Services Market - By End-User

10. Gmp Cell Banking Services Market- By Geography

11. Key Vendor Analysis- Gmp Cell Banking Services Industry

12. 360 Degree AnalystView

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â